Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients

Neurogastroenterology and Motility

Volumn 21, Issue 12, 2009, Pages

  McNearney, T A ^a   Sallam, H S ^a   Hunnicutt, S E ^a   Doshi, D ^a   Wollaston, D E ^a   Mayes, M D ^b   Chen, J D Z ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Electrogastrography; Gastric slow waves; Gastrointestinal hormones; Gastrointestinal motility; Scleroderma

Indexed keywords

GASTROINTESTINAL POLYPEPTIDE; MOTILIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; BRADYGASTRIA; CHANNEL SURFACE ELECTROGASTROPHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROGASTROGRAPHY; FEMALE; GASTRIC DYSMOTILITY; GASTRIC DYSRHYTHMIA; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOASSAY; MALE; MORBIDITY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; STOMACH DISEASE; STOMACH MOTILITY; SYSTEMIC SCLEROSIS; VISUAL ANALOG SCALE;

ADULT; DISEASE PROGRESSION; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; MOTILIN; NAUSEA; PEPTIDES; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SKIN; STOMACH; VASOACTIVE INTESTINAL PEPTIDE;

EID: 72449169630     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01350.x     Document Type: Article

References (50)

1. Sjögren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996 8 : 569 575.
2. Abu-Shakra M, Guillemin F, Lee P. Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum 1994 24 : 29 39.
3. Steen V, Medsger T. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000 43 : 2437 2444.
4. Marie I, Levesque H, Ducrotte P et al. Gastric involvement in systemic sclerosis- a prospective study. Am J Gastroenterol 2001 96 : 77 83. (Pubitemid 32104811)
5. Sallam H, McNearney T, Chen J. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther, 2006 23 : 691 712.
6. Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989 96 : 110 115.
7. Dessein PH, Joffe B, Metz RM, Millar DL, Lawson M, Stanwix AE. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992 93 : 143 150.
8. Lock G, Straub RH, Zeuner M et al. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J Rheumatol 1998 25 : 1330 1335. (Pubitemid 28312351)
9. Pfaffenbach B, Adamek RJ, Hagemann D, Wegener M. Gastric myoelectrical activity and gastric emptying in patients with progressive systemic sclerosis. Am J Gastroenterol 1996 91 : 411 413. (Pubitemid 26067377)
10. Marycz T, Muehldorfer SM, Gruschwitz MS et al. Gastric involvement in progressive systemic sclerosis: electrogastrographic and sonographic findings. Eur J Gastroenterol Hepatol 1999 11 : 1151 1156.
11. Young MA, Rose S, Reynolds JC. Gastrointestinal manifestations of scleroderma. Rheum Dis Clin North Am 1996 22 : 797 823.
12. Czirjak L, Kumanovics G, Varju C et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008 67 : 59 63.
13. Walker UA, Tyndall A, Czirjak L et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 2007 66 : 754 763.
14. Franck-Larsson K, Hedenstrom H, Dahl R, Ronnblom A. Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 2003 32 : 348 355.
15. Chen JDZ, Schirmer BD, McCallum RW. Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis. Am J Physiol 1994 266 : G90 8.
16. Simonian HP, Panganamamula K, Chen JZ, Fisher RS, Parkman HP. Multichannel electrogastrography (EGG) in symptomatic patients: a single center study. Am J Gastroenterol 2004 99 : 478 485. (Pubitemid 38524127)
17. Hasler WL, Soudah HC, Dulai G, Owyang C. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995 108 : 727 736.
18. Chen JDZ, Lin ZY, McCallum RW. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 1996 41 : 1538 1545.
19. McNearney T, Lin X, Shrestha J, Lisse J, Chen JD. Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography. Dig Dis Sci 2002 47 : 690 698.
20. Wollaston DE, Xiaohong X, Tokumara O, Chen JDZ, McNearney TA. Systemic Sclerosis (SSc) patients have unique and persistent alteration in gastric myoelectrical activity (GMA) with acupressure to Neiguan point PC6. J Rheumatol 2005 32 : 494 501.
21. Masi AT, Rodnan GP, Medsger TA Jr. et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 23 : 581 590.
22. Kahaleh M, Sultany G, Smith E, Huffstutter J, Loadholt C, LeRoy E. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986 4 : 367 369.
23. Pope JE, Bellamy N. Outcome measurement in scleroderma clinical trials. Semin Arthritis Rheum 1993 23 : 22 33.
24. Medsger TA Jr., Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003 21 : S42 6.
25. Chen JD, McCallum RW. Electrogastrographic parameters and their clinical significance. In : Chen JD, ed. Electrogastrography: Principles and Applications. NY : Raven, 1994 : 45 74.
26. Lembo T, Naliboff B, Munakata J et al. Symptoms and visceral perception in patients with pain predominant irritable bowel syndrome. Am J Gastroenterol 1999 94 : 1320 1326. (Pubitemid 29214648)
27. Groll D, Vanner S, Depew W et al. The IBS-36: a new quality of life measure for irritable bowel syndrome. Am J Gastroenterol 2002 97 : 962 971.
28. Del Rosso A, Boldrini M, Agostino D et al. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. Arthritis Rheum 2004 51 : 475 481.
29. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997 11 : 395 402.
30. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patient over time. Arthritis Rheum 1997 40 : 1984 1991.
31. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988 26 : 724 735.
32. Danieli E, Paolo A, Lorenzo B et al. Health-related quality of life measured by the Short Form 36 (S-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 2005 24 : 48 54.
33. Cossutta R, Zeni S, Soldi A, Colombelli P, Belloti Masserini A, Fantini F. Evaluation of quality of life in patients with systemic sclerosis by administering the SF-36 questionnaire. Reumatismo 2002 54 : 122 127.
34. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 : 473 448.
35. Ware JE. Measuring patients' views: the optimum outcome measure. BMJ 1993 306 : 1429 1430.
36. Sjögren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994 37 : 1265 1282.
37. Khanna D, Hays RD, Park GS et al. Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum 2007 57 : 1280 1286.
38. Matucci-Cerinic M, Giacomelli R, Pignone A et al. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis. Ann Rheum Dis 2001 60 : 487 494.
39. Owyang C. Octreotide in gastrointestinal motility disorders. Gut 1994 35 (Suppl. 3 S11 4.
40. Sjolund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A. Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 2005 17 : 1205 1212.
41. Akesson A, Ekman R. Gastrointestinal regulatory peptides in systemic sclerosis. Arthritis Rheum 1993 36 : 698 703.
42. Wang X, Gong Z, Wu K, Wang B, Yuang Y. Gastrointestinal dysmotility in patients with acute pancreatitis. J Gastroenterol Hepatol 2003 18 : 57 62.
43. Bercik P, De Giorgio R, Blennerhassett P, Verdu EF, Barbara G, Collins SM. Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology 2002 123 : 1205 1215.
44. Kawamura O, Sekiguchi T, Kusano M, Nishioka T, Itoh Z. Effect of erythromycin on interdigestive gastrointestinal contractile activity and plasma motilin concentration in humans. Dig Dis Sci 1993 38 : 870 876.
45. Cohen S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980 79 : 155 166.
46. Sallam H, McNearney TA, Doshi D, Chen JD. Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci 2007 52 : 1329 1337.
47. Ciftci O, Onat AM, Yavuz B et al. Cardiac repolarization abnormalities and increased sympathetic activity in scleroderma. J Natl Med Assoc 2007 99 : 232 237.
48. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology 2005 44 : 587 596.
49. Hesselstrand R, Scheja A, Shen GQ, Wiik A, Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology 2003 42 : 534 540.
50. Henault J, Robitaille G, Senecal JL, Raymond Y. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 2006 54 : 963 973.